Page last updated: 2024-11-08

ipalbidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

ipalbidine: photoalkaloid isolated from seeds of Ipomoea hardwickii Hemsl.; structure given in first source; RR from Chemical Abstracts Index Guide; RN given refers to (+-)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
IpomoeagenusA plant genus in the family CONVOLVULACEAE best known for morning glories (a common name also used with CONVOLVULUS) and sweet potato.[MeSH]ConvolvulaceaeThe morning glory family of flowering plants, of the order Solanales, which includes about 50 genera and at least 1,400 species. Leaves are alternate and flowers are funnel-shaped. Most are twining and erect herbs, with a few woody vines, trees, and shrubs.[MeSH]

Cross-References

ID SourceID
PubMed CID161520
SCHEMBL ID3133193
MeSH IDM0160850

Synonyms (6)

Synonym
ipalbidine
4-(7-methyl-1,2,3,5,8,8a-hexahydroindolizin-6-yl)phenol
phenol, 4-(1,2,3,5,8,8a-hexahydro-7-methyl-6-indolizinyl)-, (+-)-
26294-41-7
SCHEMBL3133193
DTXSID50949157

Research Excerpts

Overview

Ipalbidine (Ipa) is a photoactive alkaloid isolated from the seeds of ipomoea hardwickki Hemsl.

ExcerptReferenceRelevance
"Ipalbidine (Ipa) is a photoactive alkaloid isolated from the seeds of ipomoea hardwickki Hemsl. "( [Effect of norepinephrinergic system on ipalbidine analgesia].
Chu, YH; Wang, LM, 1996
)
2
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (20.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (20.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]